GeneDx Holdings WGS Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's accounts receivable?
- GeneDx Holdings (WGS) reported accounts receivable of $76.93M in Q1 2026.
- How has GeneDx Holdings's accounts receivable changed year-over-year?
- GeneDx Holdings's accounts receivable increased by 67.3% year-over-year, from $45.98M to $76.93M.
- What is the long-term trend for GeneDx Holdings's accounts receivable?
- Over 4 years (2021 to 2025), GeneDx Holdings's accounts receivable has grown at a 21.4% compound annual growth rate (CAGR), from $105.67M to $229.32M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.